Gilead CEO on promising study results for remdesivir Covid-19 treatment

Gilead Sciences released new results on its drug remdesivir for treating Covid-19. Gilead CEO Daniel O'Day joins "Squawk Box" to discuss the results and what it means for treating critical patients with the virus.
Fri, Oct 9 20207:21 AM EDT